Markus Tiemann

Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.

Alfred Reiter, Martin Schrappe, Markus Tiemann et al. · Journal of Clinical Oncology · 1994 · 208 citations

Medicine, Hematology, Oncology +17

Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors

Melanie Janning, Franca Kobus, Anna Babayan et al. · Cancers · 2019 · 138 citations · Full text

Medicine, Cancer Biology, Oncology +17

The bisphosphonate zoledronic acid has antimyeloma activity<i>in vivo</i>by inhibition of protein prenylation

Andreas Guenther, Sharon Gordon, Markus Tiemann et al. · International Journal of Cancer · 2009 · 122 citations · Full text

Medicine, Oncology, Pharmacology +12

Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study

Albrecht Stenzinger, Volker Endris, Jan Budczies et al. · Journal of Thoracic Oncology · 2020 · 112 citations · Full text

Medicine, Oncology, Pathology +16

Interlaboratory concordance of <scp>PD</scp>‐L1 immunohistochemistry for non‐small‐cell lung cancer

Andreas H. Scheel, Gudrun Baenfer, Gustavo Baretton et al. · Histopathology · 2017 · 80 citations · Full text

Medicine, Oncology, Pathology +17